Gene: ZCCHC12
Official Full Name: zinc finger CCHC-type containing 12provided by HGNC
Gene Summary: This gene encodes a downstream effector of bone morphogenetic protein (BMP) signalling. This protein contains a zinc finger domain and functions as a transcriptional coactivator. Variation in this gene may be associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12441 | ZCCHC12 Knockout cell line (HCT 116) | Human | ZCCHC12 | 1:2~1:4 | Negative | Online Inquiry |
KO12442 | ZCCHC12 Knockout cell line (HEK293) | Human | ZCCHC12 | 1:3~1:6 | Negative | Online Inquiry |
ZCCHC12 Gene Knockout Cell Lines are genetically engineered cell lines in which the ZCCHC12 gene has been systematically disrupted. This innovative product serves as a crucial tool for scientists and researchers investigating the biological roles of ZCCHC12, a gene implicated in various cellular processes, including RNA metabolism and cellular signaling pathways. By employing CRISPR-Cas9 technology to create precise gene knockouts, these cell lines facilitate the functional analysis of ZCCHC12, enabling researchers to elucidate its contributions to disease mechanisms, such as cancer progression and neurodegenerative disorders.
The primary function of these knockout cell lines is to allow for the detailed study of ZCCHC12's role at both molecular and cellular levels. They enable researchers to assess gene function through various assays, such as proliferation studies, apoptosis assays, and gene expression profiling. As ZCCHC12 is associated with key regulatory pathways, understanding its function could lead to significant insights in therapeutic developments and biomarker discovery.
The scientific importance of ZCCHC12 Gene Knockout Cell Lines is underscored by their utility in research and clinical settings. They are invaluable in drug discovery, allowing for the identification of novel therapeutic targets and understanding drug response in specific pathways. Additionally, they facilitate studies in cancer biology, immunology, and genetic disorders.
One of the unique selling points of our ZCCHC12 Gene Knockout Cell Lines is the rigor with which they have been validated. Unlike alternative models, these lines come with a comprehensive characterization report, ensuring that researchers can trust the functionality of the knockout and the reproducibility of their findings. Coupled with the ease of use in standard cell culture protocols, these cell lines provide a streamlined approach to studying gene functions.
By choosing our ZCCHC12 Gene Knockout Cell Lines, researchers gain access to a reliable and cutting-edge tool that can accelerate their research efforts and contribute to innovative solutions in science and medicine. Our company prides itself on its expertise in gene editing technologies and commitment to providing high-quality biological products that empower discovery and enhance research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.